287 related articles for article (PubMed ID: 25347154)
1. Methods for detecting circulating cancer stem cells (CCSCs) as a novel approach for diagnosis of colon cancer relapse/metastasis.
Kantara C; O'Connell MR; Luthra G; Gajjar A; Sarkar S; Ullrich RL; Singh P
Lab Invest; 2015 Jan; 95(1):100-12. PubMed ID: 25347154
[TBL] [Abstract][Full Text] [Related]
2. Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.
Zhang Z; Bu X; Chen H; Wang Q; Sha W
Int J Mol Med; 2016 Oct; 38(4):1199-207. PubMed ID: 27600678
[TBL] [Abstract][Full Text] [Related]
3. Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer.
Lee CH; Hsieh JC; Wu TM; Yeh TS; Wang HM; Lin YC; Chen JS; Lee CL; Huang WK; Hung TM; Yen TT; Chan SC; Chou WC; Kuan FC; Hu CC; Chang PH
BMC Cancer; 2019 Dec; 19(1):1167. PubMed ID: 31791269
[TBL] [Abstract][Full Text] [Related]
4. Isolating Circulating Cancer Stem Cells (CCSCs) from Human Whole Blood.
Kantara C; Singh P
Methods Mol Biol; 2024; 2777():205-218. PubMed ID: 38478346
[TBL] [Abstract][Full Text] [Related]
5. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
Mitra A; Mishra L; Li S
Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
[TBL] [Abstract][Full Text] [Related]
6. Triptolide inhibits CD133
Acikgoz E; Tatar C; Oktem G
J Cell Biochem; 2020 Jun; 121(5-6):3313-3324. PubMed ID: 31904143
[TBL] [Abstract][Full Text] [Related]
7. Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment.
Malara N; Trunzo V; Foresta U; Amodio N; De Vitis S; Roveda L; Fava M; Coluccio M; Macrì R; Di Vito A; Costa N; Mignogna C; Britti D; Palma E; Mollace V
J Transl Med; 2016 May; 14(1):133. PubMed ID: 27176720
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
Huang R; Rofstad EK
Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
[TBL] [Abstract][Full Text] [Related]
9. [Cancer stemness and circulating tumor cells].
Saito T; Mimori K
Nihon Rinsho; 2015 May; 73(5):806-10. PubMed ID: 25985635
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
[TBL] [Abstract][Full Text] [Related]
11. Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells.
Wang Q; Liu F; Wang L; Xie C; Wu P; Du S; Zhou S; Sun Z; Liu Q; Yu L; Liu B; Li R
Int J Nanomedicine; 2020; 15():1283-1295. PubMed ID: 32161458
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.
Giordano A; Gao H; Anfossi S; Cohen E; Mego M; Lee BN; Tin S; De Laurentiis M; Parker CA; Alvarez RH; Valero V; Ueno NT; De Placido S; Mani SA; Esteva FJ; Cristofanilli M; Reuben JM
Mol Cancer Ther; 2012 Nov; 11(11):2526-34. PubMed ID: 22973057
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer.
Papadaki MA; Stoupis G; Theodoropoulos PA; Mavroudis D; Georgoulias V; Agelaki S
Mol Cancer Ther; 2019 Feb; 18(2):437-447. PubMed ID: 30401696
[TBL] [Abstract][Full Text] [Related]
14. Human circulating and tissue gastric cancer stem cells display distinct epithelial-mesenchymal features and behaviors.
Zhang S; Shang Y; Chen T; Zhou X; Meng W; Fan C; Lu R; Huang Q; Li X; Hong X; Zhou Z; Hu J; Mo X
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1687-1699. PubMed ID: 28429101
[TBL] [Abstract][Full Text] [Related]
15. miR-139-5p reverses stemness maintenance and metastasis of colon cancer stem-like cells by targeting E2-2.
Ma X; Liu J; Li J; Li Y; Le VM; Li S; Liang X; Liu L; Liu J
J Cell Physiol; 2019 Dec; 234(12):22703-22718. PubMed ID: 31120140
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological significance of circulating tumor cells in cancer.
Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
[TBL] [Abstract][Full Text] [Related]
17. Real-time in vivo imaging of subpopulations of circulating tumor cells using antibody conjugated quantum dots.
Kuo CW; Chueh DY; Chen P
J Nanobiotechnology; 2019 Feb; 17(1):26. PubMed ID: 30728024
[TBL] [Abstract][Full Text] [Related]
18. Selective isolation and noninvasive analysis of circulating cancer stem cells through Raman imaging.
Cho HY; Hossain MK; Lee JH; Han J; Lee HJ; Kim KJ; Kim JH; Lee KB; Choi JW
Biosens Bioelectron; 2018 Apr; 102():372-382. PubMed ID: 29174970
[TBL] [Abstract][Full Text] [Related]
19. The critical role of peroxiredoxin-2 in colon cancer stem cells.
Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Fu Z
Aging (Albany NY); 2021 Mar; 13(8):11170-11187. PubMed ID: 33819194
[TBL] [Abstract][Full Text] [Related]
20. Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells.
Leng Z; Tao K; Xia Q; Tan J; Yue Z; Chen J; Xi H; Li J; Zheng H
PLoS One; 2013; 8(2):e56082. PubMed ID: 23418515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
